Quick Answer
Cytosorbents Corp reported Long-Term Debt of $16.67 million for fiscal year 2025.
Cytosorbents Corp Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $16.67M | +19.1% |
| 2024 | $14.00M | +450.4% |
| 2023 | $2.54M | -49.1% |
| 2022 | $5.00M | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $13.39M | +44.3% |
| 2018 | $9.27M | +54.8% |
| 2017 | $5.99M | +46.9% |
| 2016 | $4.08M | — |
| 2015 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.57M | +5.5% | +1.3% |
| June 30, 2025 | $14.38M | +5.1% | +1.3% |
| March 31, 2025 | $14.19M | +635.6% | +1.4% |
| December 31, 2024 | $14.00M | +450.4% | +1.4% |
| September 30, 2024 | $13.81M | +228.8% | +1.0% |
| June 30, 2024 | $13.67M | +172.3% | +609.0% |
| March 31, 2024 | $1.93M | — | -24.2% |
| December 31, 2023 | $2.54M | -49.1% | -39.4% |
- Cytosorbents Corp showed an increase of +19.1% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Cytosorbents Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: